Finger Hardness Measure in Scleroderma
NCT01111786 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2014-06-26
Summary
Thirty subjects with systemic sclerosis and 30 age and sex matched controls without any known condition that should cause increased skin hardness in the fingers with undergo examination by manual palpation and durometer measured hardness of their digital tuft skin by 2 observers on 2 separate occasions. There will be 1 hour between individual observer's scorings. Observers will be blinded from the observer's scores and from their previous scores. Results will be tabulated and compared for manual scores versus durometer measurements, intra-observer scores by both methods and inter-observer scores by both methods.
Conditions
- Scleroderma
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Thomas Osborn, MD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2013-01-31
- Completion
- 2013-01-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
NCT02165111 ·Status: COMPLETED ·Phase: PHASE3
-
Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
NCT06291142 ·Status: COMPLETED
-
Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at Scleroderma (SSc) Patients Compared Healthy Peoples
NCT01553890 ·Status: UNKNOWN ·Phase: NA
-
Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?
NCT05482594 ·Status: UNKNOWN
-
Calcinosis in a Single-Center Scleroderma Population
NCT02062125 ·Status: COMPLETED
-
Trichoscopy and Systemic Scleroderma
NCT04804930 ·Status: RECRUITING
-
Metabolomic Analysis of Systemic Sclerosis
NCT02298777 ·Status: TERMINATED
-
6-minute Pegboard Ring Test in Patients with Scleroderma
NCT06588959 ·Status: NOT_YET_RECRUITING
-
Self-management Telehealth Program for Scleroderma
NCT06990386 ·Status: COMPLETED ·Phase: NA
-
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
NCT07090226 ·Status: RECRUITING ·Phase: NA
-
Western Sweden Systemic Sclerosis Project
NCT07345052 ·Status: RECRUITING
-
NVC Test in Order to Assess Pathological Changes in Family Members of Patient Diagnosed With SSc
NCT02795221 ·Status: UNKNOWN
-
Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear
NCT00218868 ·Status: COMPLETED
-
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT01743612 ·Status: COMPLETED ·Phase: NA
-
Microvascular and Fibrosis Imaging Study
NCT01758250 ·Status: COMPLETED
-
Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
NCT02349009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma
NCT07256418 ·Status: RECRUITING
-
Effects of FT011 in Systemic Sclerosis
NCT04647890 ·Status: COMPLETED ·Phase: PHASE2
-
Repurposing Anti-TNF for Treating Dupuytren's Disease
NCT03180957 ·Status: COMPLETED ·Phase: PHASE2
-
Utility of Breath-holding Test in Systemic Sclerosis
NCT04484948 ·Status: COMPLETED ·Phase: NA
-
Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images
NCT07228429 ·Status: RECRUITING
-
Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis
NCT02558543 ·Status: TERMINATED ·Phase: PHASE2
-
Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis
NCT00869479 ·Status: COMPLETED
-
The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )
NCT03059979 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
UVA-1 for Treatment of Skin Tightening and Improvement of Hand Function in Scleroderma
NCT04875078 ·Status: ENROLLING_BY_INVITATION ·Phase: NA